Connecting Data to People

Integrated Testing Strategy for Skin Sensitisation

 

Allergic contact dermatitis (aka., skin sensitisation) accounts for 20% of all contact dermatitis cases and has an estimated annual cost of $200 million. It is also a public health problem, responsible for more than seven million outpatient visits annually. Currently, there are more than 3700 substances that are identified as contact allergens.

Douglas Connect provides an open implementation of the integrated testing strategy (ITS) that assesses skin sensitisation potency based on an approach developed at Proctor and Gamble.

The DC-ITS implementation combines information from three validated alternative assays (DPRA, KeratinoSens and h-CLAT) with in silico predictions for bioavailability using open cheminformatics tools from the community.

DC-ITS allows scientists to evaluate the skin sensitisation hazard of their chemicals using a combination of in vitro and in silico tools. It automatically compensates for the missing experimental data by using predicted values and utilizes the expert-knowledge embedded in the skin sensitization adverse outcome pathway (AOP). More

 

 

Dr Ahmed Abdelaziz
Safety Scientist

 

 

 

 

Rok Predan
Community Manager

 

Please visit our ITS posters during SOT:

Assist—A Platform for Supporting Regulatory Assessment of Chemicals' Toxicity toward Filling REACH Information Gaps
Presented by Ahmed Abdelaziz
Abstract Number/Poster Board number: 1388/P126
Session Title: Bioinformatics and Tox Databases
March 13 1:15pm to 4:30pm
CC Exhibit Hall or Hall A

An Integrated Decision Strategy Development for Skin Sensitization Assessment
Presented by Thomas Exner
Abstract Number/Poster Board number: 2948/P442
Session Title: Quantitative Systems Toxicology
March 15 1:15pm to 4:30pm
CC Exhibit Hall or Hall A

 

DC CONNECTIONS

Latest Tweets

Douglas Connect (16 hours ago)
RT @barryhardy: #WC10 #3Rs #Seattle discuss with @DouglasConn Integrated Testing platform for Alternatives to Animal Testing! https://t.co/…
Douglas Connect (3 days ago)
Meet us in Seattle, at the 10th World Congress on Alternatives and Animal Use in the Life Sciences, Booth 405 https://t.co/FiSgRl16wD
Douglas Connect (3 days ago)
RT @barryhardy: Advancing best practice in #risk #assessment #reporting #silico #WC10 #OpenTox #OpenRiskNet @EUToxRisk @DouglasConn https:/…
Douglas Connect (5 days ago)
RT @barryhardy: #WC10 @DouglasConn Discuss with Douglas Connect #OpenTox #Garuda #Interoperability with Time Savings but no Lock-in! https:…
Douglas Connect (5 days ago)
RT @barryhardy: #WC10 discuss with @DouglasConn Team @EU_ToxRisk knowledge management, challenges in validation, commercialisation and regu…

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com